USPTO Examiner GEDRA OLIVIA ROSE - Art Unit 3681

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
18291603GUIDING A SUBJECT THROUGH A CARE OR TREATMENT SELECTION PROCESSJanuary 2024March 2026Abandon2610NoNo
18384608Protocol for a Cloud Based AI Clinical Decision Support System for Primary CareOctober 2023December 2025Abandon2510NoNo
18273176COMPUTER-ASSISTED RECOMMENDATION OF INPATIENT OR OUTPATIENT CARE FOR SURGERYJuly 2023November 2025Abandon2810NoNo
18209250DATA STRUCTURE SUPPORTING CLINICAL STUDY CREATION, DISTRIBUTION AND FISCAL COMPONENTSJune 2023November 2025Abandon2910NoNo
18330426Procedure and Prediction System to Determine the Probability of a Patient Suffering from SepsisJune 2023October 2025Abandon2810YesNo
18203729DIAGNOSTIC DISEASE PREDICTION AND THERAPEUTIC PLAN RECOMMENDATION SYSTEM THROUGH ARTIFICIAL INTELLIGENCE QUESTIONNAIRE ANALYSIS AND METHOD THEREOFMay 2023October 2025Abandon2810NoNo
18322282PREDICTIVE CLINICAL DATA CONSUMABILITY VALUATIONMay 2023January 2026Abandon3210YesNo
18199385INTELLIGENT RULES BASED METHODOLOGY AND SYSTEM TO PROVIDE PREDICTIVE PATIENT STATUS MONITORING AND ALERTSMay 2023June 2025Abandon2510NoNo
18012167STRESS COPING MANAGEMENT APPARATUS, STRESS COPING MANAGEMENT METHOD, AND COMPUTER-READABLE RECORDING MEDIUMDecember 2022January 2026Abandon3610YesNo
18046703METHODS AND SYSTEMS FOR VIDEO COLLABORATIONOctober 2022January 2026Abandon4010NoNo
17652133HEALTH SUPPORT APPARATUS, HEALTH SUPPORT METHOD, AND RECORDING MEDIUM RECORDING HEALTH SUPPORT PROGRAMFebruary 2022December 2025Abandon4520NoNo
17394558VIRTUAL REALITY ACTIVITIES FOR VARIOUS IMPAIRMENTSAugust 2021May 2025Abandon4510NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner GEDRA, OLIVIA ROSE - Prosecution Strategy Guide

Executive Summary

Examiner GEDRA, OLIVIA ROSE works in Art Unit 3681 and has examined 1 patent applications in our dataset. With an allowance rate of 0.0%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 45 months.

Allowance Patterns

Examiner GEDRA, OLIVIA ROSE's allowance rate of 0.0% places them in the 1% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by GEDRA, OLIVIA ROSE receive 1.00 office actions before reaching final disposition. This places the examiner in the 9% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by GEDRA, OLIVIA ROSE is 45 months. This places the examiner in the 13% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 39% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Prepare for rigorous examination: With a below-average allowance rate, ensure your application has strong written description and enablement support. Consider filing a continuation if you need to add new matter.
  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.